obesity

Serious side effects raise safety questions for new weight-loss drugs In recent years, glucagon-like peptide-1 receptor agonists (GLP-1), such as semaglutide and liraglutide (marketed respectively as Wegovy and Ozempic), have…

The pharmaceutical company Eli Lilly has launched single dose vials of Zepbound, a cheaper version of tirzepatide The battle against obesity has taken a significant step forward with the introduction of a new, cheaper version of…

New study presents a tool to determine the need for coronary angioplasty through AI The battle against obesity may have found a new ally. Amicretina, an experimental pill developed by Novo Nordisk, has shown promising results in a phase I…